Introduction
Obesity and type 2 diabetes affect millions of people in India. With the growing demand for effective weight management solutions, many people want to know whether Eli Lilly’s Mounjaro is available in India and if it has regulatory approval. Several weight loss drugs exist in India, but only a few are considered effective and safe. This article explores Eli Lilly’s weight loss drug Mounjaro in India, its approval status, price, and availability.
Eli Lilly’s Presence in India
Eli Lilly, a leading pharmaceutical company, has operated in India for several years. The company specializes in innovative treatments for diabetes, obesity, and other chronic conditions. Lilly’s portfolio includes Trulicity, Humalog, and now Mounjaro, providing better options for patients needing advanced therapies.
Which Weight Loss Drugs Are Approved in India?
India’s Central Drugs Standard Control Organization (CDSCO) has approved several weight loss drugs. Doctors prescribe these medications based on individual patient needs. Some common weight loss drugs approved in India include:
1. Orlistat
Doctors commonly prescribe Orlistat, a lipase inhibitor that blocks fat absorption in the intestine. This drug reduces calorie intake and helps patients lose weight with a balanced diet and exercise.
Also read- Supplements You Should Avoid Taking Without Consulting an Expert
2. Liraglutide (Saxenda)
Liraglutide, marketed as Saxenda, belongs to the GLP-1 receptor agonist class. It works by regulating appetite and promoting satiety, making it a popular weight-loss choice.
3. Naltrexone-Bupropion (Contrave)
Naltrexone-bupropion, available under the brand name Contrave, affects the brain’s reward system and appetite control centers. This drug helps reduce cravings and emotional eating.
4. Semaglutide (Wegovy)
Semaglutide, marketed as Wegovy, is another GLP-1 receptor agonist that aids weight loss. Although it is available in some countries, its availability in India remains limited.
Does Eli Lilly Have a Weight Loss Drug?
Yes, Eli Lilly manufactures Mounjaro (tirzepatide), a weight loss drug approved for treating type 2 diabetes and obesity. Initially developed as a diabetes treatment, Mounjaro has demonstrated significant weight loss benefits in clinical trials. The U.S. FDA approved it for weight management, leading to increased demand worldwide.
Is Mounjaro Approved for Weight Loss in India?
Yes, India’s drug regulatory authority has approved Mounjaro for use. Eli Lilly officially launched the drug in India, making it available for patients with type 2 diabetes and those struggling with obesity. The approval marks a significant advancement in weight loss treatments in India.
How Mounjaro Works for Weight Loss
Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist. This drug works by:
- Slowing Digestion – It delays gastric emptying, keeping you full longer and reducing calorie intake.
- Regulating Blood Sugar – Mounjaro lowers blood sugar, improving metabolism.
- Suppressing Appetite – It affects brain signals that control hunger, leading to reduced food cravings.
Mounjaro’s Price and Availability in India
Eli Lilly launched Mounjaro in India at a competitive price, making it accessible to patients. The pricing structure is as follows:
- 5 mg vial – ₹4,375
- 2.5 mg vial – ₹3,500
The drug is available in leading hospitals, pharmacies, and through online prescription platforms. Patients should consult their doctors before using Mounjaro for weight loss.
Conclusion
Eli Lilly’s Mounjaro is now available in India, providing a new option for weight loss and diabetes treatment. The drug’s approval represents a breakthrough in obesity management, offering patients an effective way to lose weight. However, individuals must seek medical guidance before starting Mounjaro to ensure safety and effectiveness.